Log on / register
Feedback | Support | My details

Pre-publication history

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Andrew Spencer email, Andrew Roberts email, Nola Kennedy email, Christina Ravera email, Serge Cremers email, Sanela Bilic email, Terry Neeman email, Michael Copeman email, Horst Schran email and Kevin Lynch email

BMC Clinical Pharmacology 2008, 8:2doi:10.1186/1472-6904-8-2

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript07 Jun 2007
Reviewer's ReportAntonio Palumbo23 Aug 2007
Reviewer's ReportStathis Kastritis08 Sep 2007
Resubmission - Version 4Manuscript12 Nov 2007
Resubmission - Version 6Manuscript31 Mar 2008
Accepted31 Mar 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated